.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Randomized trials have demonstrated that administering magnesium sulfate before anticipated very preterm birth reduces the risk of cerebral palsy and substantial gross motor dysfunction in surviving children. For maternal-fetal medicine teams, the practical issue is recognizing when delivery is sufficiently imminent to justify treatment and administering it early enough to provide benefit. This indication is distinct from magnesium sulfate for seizure prophylaxis in preeclampsia, and protocols should clearly separate the two. The evidence supports incorporating fetal neuroprotection into standardized preterm-delivery pathways, particularly in tertiary centers where transfer and neonatal care can be coordinated.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Randomized trials have demonstrated that administering magnesium sulfate before anticipated very preterm birth reduces the risk of cerebral palsy and substantial gross motor dysfunction in surviving children. For maternal-fetal medicine teams, the practical issue is recognizing when delivery is sufficiently imminent to justify treatment and administering it early enough to provide benefit. This indication is distinct from magnesium sulfate for seizure prophylaxis in preeclampsia, and protocols should clearly separate the two. The evidence supports incorporating fetal neuroprotection into standardized preterm-delivery pathways, particularly in tertiary centers where transfer and neonatal care can be coordinated.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
